News
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care setzt sich Klimaziele: Klimaneutralität bis 2040, Halbierung der CO2-Emissionen bis 2030
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care erfüllt Prognose und strebt für 2022 Rückkehr zu Gewinnwachstum an
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers on 2021 guidance, targets return to earnings growth in 2022
Quidel Reports Fourth Quarter and Full Year 2021 Financial Results
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the
Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity
Agilent Technologies Inc. (NYSE: A) today announced it has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine learning software developer that
DGAP-News: Gerresheimer AG: Gerresheimer beschleunigt Wachstum und hebt mittelfristige Prognose an
DGAP-News: Gerresheimer AG: Gerresheimer accelerates growth and raises mid-term guidance
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2021 Earnings Release
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2021 results on Monday, February 28, 2022, after the close of the market. Acadia
Humana, the Humana Foundation and UofL Announce up to $25 Million Investment in Health Equity Innovation Hub
Humana Inc. (NYSE: HUM), The Humana Foundation and the University of Louisville today announced a new cooperative agreement and additional financial investment in the university’s Health Equity
DGAP-HV: Carl Zeiss Meditec AG: Bekanntmachung der Einberufung zur Hauptversammlung am 30.03.2022 in Jena mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: Carl Zeiss Meditec AG: Bekanntmachung der Einberufung zur Hauptversammlung am 30.03.2022 in Jena mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Agilent Announces Cash Dividend of 21 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on April 27, 2022, to all shareholders of record as of the close of
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced the appointment
Dexcom Announces Upcoming Virtual Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences:
-
Brice Bobzien, Vice President, Finance
Dexcom Announces Upcoming Virtual Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences:
-
Brice Bobzien, Vice President, Finance
DGAP-News: Carl Zeiss Meditec achieves further growth in first quarter of 2021/22
DGAP-News: Carl Zeiss Meditec achieves further growth in first quarter of 2021/22
DGAP-News: Carl Zeiss Meditec erzielt weiteres Wachstum im ersten Quartal 2021/22
DGAP-News: Carl Zeiss Meditec erzielt weiteres Wachstum im ersten Quartal 2021/22
Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2021.
Fourth Quarter 2021 Financial Highlights:
-
Revenue grew 23%
Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2021.
Fourth Quarter 2021 Financial Highlights:
-
Revenue grew 23%
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release
NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a